Anti-INPP4B antibody [EPR3108Y]
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
0
(1 Review)
|
(15 Publications)
Rabbit Recombinant Monoclonal INPP4B antibody. Suitable for WB, IHC-P, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 15 publications.
View Alternative Names
Inositol polyphosphate 4-phosphatase type II, INPP4B
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-INPP4B antibody [EPR3108Y] (AB81269)
Immunocytochemistry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling INPP4B with Purified ab81269 at 1 : 50 dilution (2.4 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-INPP4B antibody [EPR3108Y] (AB81269)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human lung carcinoma tissue sections labeling INPP4B with Purified ab81269 at 1 : 50 dilution (2.36 µg/ml). Heat mediated antigen retrieval was performed using Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0) . Tissue was counterstained with Hematoxylin. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-INPP4B antibody [EPR3108Y] (AB81269)
Intracellular Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling INPP4B with purified ab81269 at 1/100 dilution (10 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cells without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-INPP4B antibody [EPR3108Y] (AB81269)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma tissue sections labeling INPP4B with Purified ab81269 at 1 : 50 dilution (2.36 µg/ml). Heat mediated antigen retrieval was performed using Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0) . Tissue was counterstained with Hematoxylin. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.
- WB
Unknown
Western blot - Anti-INPP4B antibody [EPR3108Y] (AB81269)
INPP4B is lowly expressed in PANC-1 (PMID : 29952716)
All lanes:
Western blot - Anti-INPP4B antibody [EPR3108Y] (ab81269) at 1/1000 dilution
Lane 1:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Human skeletal muscle lysate at 20 µg
Lane 3:
A-204 (Human muscle rhabdomyosarcoma) whole cell lysate at 20 µg
Lane 4:
PANC-1 (Human pancreatic epithelioid carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 105 kDa
Observed band size: 107 kDa
false
Related conjugates and formulations (10)
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-INPP4B antibody [EPR3108Y]
-
Anti-INPP4B antibody [EPR3108Y] - BSA and Azide free
-
578 PE
PE Anti-INPP4B antibody [EPR3108Y]
-
660 APC
APC Anti-INPP4B antibody [EPR3108Y]
-
HRP Anti-INPP4B antibody [EPR3108Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-INPP4B antibody [EPR3108Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-INPP4B antibody [EPR3108Y]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-INPP4B antibody [EPR3108Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-INPP4B antibody [EPR3108Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-INPP4B antibody [EPR3108Y]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
INPP4B participates in regulating intracellular signaling pathways and maintaining cellular homeostasis. It is a negative regulator of the PI3K/AKT signaling cascade a critical pathway controlling cell growth proliferation survival and metabolism. INPP4B acts as a tumor suppressor modulating signals that impact cellular transformation and tumorigenesis. While not known to form a complex itself it indirectly influences complexes within the cascade through its regulatory functions.
Pathways
INPP4B contributes to the PI3K/AKT and mTOR pathways. It regulates PI3K/AKT signaling by decreasing levels of PI(34)P2 therefore modulating AKT activity. This action makes it an essential component in controlling mTOR signaling which affects protein synthesis and autophagy. INPP4B closely interacts with other signaling proteins like PTEN also a phosphatase which further lowers PI3K signaling by dephosphorylating PI(345)P3 to PI(45)P2.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Turkish journal of haematology : official journal of Turkish Society of Haematology 42:82-91 PubMed39960210
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 14: PubMed35158790
2022
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 21:433 PubMed33879096
2021
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 117:26347-26355 PubMed33020300
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer discovery 10:1226-1239 PubMed32513774
2020
Applications
Unspecified application
Species
Unspecified reactive species
RSC advances 9:39495-39504 PubMed35540690
2019
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 12:8287-8299 PubMed31632078
2019
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 15:929-941 PubMed31182914
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 119:9899-9909 PubMed30132953
2018
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 8:1090 PubMed29061961
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com